{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:58:07Z","timestamp":1790639887274,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Ministry of Science and ICT","award":["NRF-2017R1A5A2014768"],"award-info":[{"award-number":["NRF-2017R1A5A2014768"]}]},{"name":"the Ministry of Health and Welfare of the Republic of Korea","award":["RS-2023-KH135855"],"award-info":[{"award-number":["RS-2023-KH135855"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90160-7","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T10:48:56Z","timestamp":1739616536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Identifying robust biomarkers for the diagnosis and subtype distinction of inflammatory bowel disease through comprehensive serum metabolomic profiling"],"prefix":"10.1038","volume":"15","author":[{"given":"Ji Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Ho","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Hyuk","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Ju","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeji","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosep","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Kyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"issue":"10114","key":"90160_CR1","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng, S. C. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet 390(10114), 2769\u20132778 (2017).","journal-title":"Lancet"},{"issue":"3","key":"90160_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2019.04.016","volume":"157","author":"D Piovani","year":"2019","unstructured":"Piovani, D. et al. Environmental risk factors for inflammatory bowel diseases: An umbrella review of meta-analyses. Gastroenterology. 157(3), 647\u2013659 (2019).","journal-title":"Gastroenterology."},{"key":"90160_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7247238","volume":"2019","author":"Q Guan","year":"2019","unstructured":"Guan, Q. A comprehensive review and update on the pathogenesis of inflammatory bowel disease. J. Immunol. Res. 2019, 1\u201316 (2019).","journal-title":"J. Immunol. Res."},{"issue":"3","key":"90160_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/ecco-jcc\/jjab141","volume":"16","author":"R Feakins","year":"2022","unstructured":"Feakins, R. et al. ECCO topical review on clinicopathological spectrum and differential diagnosis of inflammatory bowel disease. J. Crohns Colitis. 16(3), 343\u2013368 (2022).","journal-title":"J. Crohns Colitis."},{"key":"90160_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-021-01838-x","volume":"21","author":"Y Lu","year":"2021","unstructured":"Lu, Y. et al. Development and validation of a new algorithm model for differential diagnosis between Crohn\u2019s disease and intestinal tuberculosis: A combination of laboratory, imaging and endoscopic characteristics. BMC. Gastroenterol. 21, 1\u20139 (2021).","journal-title":"BMC. Gastroenterol."},{"issue":"6","key":"90160_CR6","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2017.08.028","volume":"153","author":"S Nikolaus","year":"2017","unstructured":"Nikolaus, S. et al. Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases. Gastroenterology. 153(6), 1504\u20131516 (2017).","journal-title":"Gastroenterology."},{"issue":"7","key":"90160_CR7","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/ibd\/izy103","volume":"24","author":"MA Sofia","year":"2018","unstructured":"Sofia, M. A. et al. Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis. Inflamm. Bowel. Dis. 24(7), 1471\u20131480 (2018).","journal-title":"Inflamm. Bowel. Dis."},{"issue":"10","key":"90160_CR8","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/ibd\/izad080","volume":"29","author":"R Ma","year":"2023","unstructured":"Ma, R. et al. A novel serum metabolomic panel for the diagnosis of Crohn\u2019s disease. Inflamm. Bowel. Dis. 29(10), 1524\u20131535 (2023).","journal-title":"Inflamm. Bowel. Dis."},{"key":"90160_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.814839","volume":"9","author":"H Liu","year":"2022","unstructured":"Liu, H. et al. Untargeted serum metabolomics reveals specific metabolite abnormalities in patients with Crohn\u2019s disease. Front. Med. 9, 814839 (2022).","journal-title":"Front. Med."},{"issue":"7","key":"90160_CR10","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/ibd\/izy402","volume":"25","author":"U Daniluk","year":"2019","unstructured":"Daniluk, U. et al. Untargeted metabolomics and inflammatory markers profiling in children with Crohn\u2019s disease and ulcerative colitis\u2014A preliminary study. Inflamm. Bowel. Dis. 25(7), 1120\u20131128 (2019).","journal-title":"Inflamm. Bowel. Dis."},{"issue":"4","key":"90160_CR11","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1053\/j.gastro.2022.05.050","volume":"163","author":"M Ghiboub","year":"2022","unstructured":"Ghiboub, M. et al. Metabolome changes with diet-induced remission in pediatric Crohn\u2019s disease. Gastroenterology. 163(4), 922\u2013936 (2022).","journal-title":"Gastroenterology."},{"issue":"6","key":"90160_CR12","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/apt.15141","volume":"49","author":"AH Keshteli","year":"2019","unstructured":"Keshteli, A. H. et al. Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: New insights into pathophysiology and potential biomarkers. Aliment. Pharmacol. Ther. 49(6), 723\u2013732 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"90160_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/ibd\/izx070","volume":"24","author":"AH Keshteli","year":"2018","unstructured":"Keshteli, A. H. et al. A distinctive urinary metabolomic fingerprint is linked with endoscopic postoperative disease recurrence in Crohn\u2019s disease patients. Inflamm. Bowel. Dis. 24(4), 861\u2013870 (2018).","journal-title":"Inflamm. Bowel. Dis."},{"issue":"11","key":"90160_CR14","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/ecco-jcc\/jjy101","volume":"12","author":"F Probert","year":"2018","unstructured":"Probert, F. et al. Plasma nuclear magnetic resonance metabolomics discriminates between high and low endoscopic activity and predicts progression in a prospective cohort of patients with ulcerative colitis. J. Crohns Colitis. 12(11), 1326\u20131337 (2018).","journal-title":"J. Crohns Colitis."},{"issue":"1","key":"90160_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a000588","volume":"1","author":"CB Clish","year":"2015","unstructured":"Clish, C. B. Metabolomics: An emerging but powerful tool for precision medicine. Mol. Case. Stud. 1(1), 000588 (2015).","journal-title":"Mol. Case. Stud."},{"issue":"5","key":"90160_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/ecco-jcc\/jjaa227","volume":"15","author":"K Gallagher","year":"2021","unstructured":"Gallagher, K., Catesson, A., Griffin, J. L., Holmes, E. & Williams, H. R. Metabolomic analysis in inflammatory bowel disease: A systematic review. J. Crohns Colitis. 15(5), 813\u2013826 (2021).","journal-title":"J. Crohns Colitis."},{"issue":"2","key":"90160_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser, C. et al. ECCO-ESGAR guideline for diagnostic assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J. Crohns Colitis. 13(2), 144\u2013164 (2019).","journal-title":"J. Crohns Colitis."},{"issue":"12","key":"90160_CR18","doi-asserted-by":"publisher","first-page":"e0144872","DOI":"10.1371\/journal.pone.0144872","volume":"10","author":"J Dong","year":"2015","unstructured":"Dong, J. et al. Body mass index is associated with inflammatory bowel disease: A systematic review and meta-analysis. PLoS ONE 10(12), e0144872 (2015).","journal-title":"PLoS ONE"},{"issue":"1","key":"90160_CR19","doi-asserted-by":"publisher","first-page":"31131","DOI":"10.1371\/journal.pone.0031131","volume":"7","author":"T Hisamatsu","year":"2012","unstructured":"Hisamatsu, T. et al. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease. PLOS ONE 7(1), 31131 (2012).","journal-title":"PLOS ONE"},{"key":"90160_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-017-1311-y","volume":"14","author":"EA Scoville","year":"2018","unstructured":"Scoville, E. A. et al. Alterations in lipid, amino acid, and energy metabolism distinguish Crohn\u2019s disease from ulcerative colitis and control subjects by serum metabolomic profiling. Metabolomics. 14, 1 (2018).","journal-title":"Metabolomics."},{"issue":"9","key":"90160_CR21","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.12998\/wjcc.v10.i9.2660","volume":"10","author":"L Zheng","year":"2022","unstructured":"Zheng, L., Wen, X. L. & Duan, S. L. Role of metabolites derived from gut microbiota in inflammatory bowel disease. World. J. Clin. Cases. 10(9), 2660\u20132677 (2022).","journal-title":"World. J. Clin. Cases."},{"key":"90160_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.freeradbiomed.2017.01.009","volume":"104","author":"O Zhenyukh","year":"2017","unstructured":"Zhenyukh, O. et al. High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation. Free. Radic. Biol. Med. 104, 165\u2013177 (2017).","journal-title":"Free. Radic. Biol. Med."},{"issue":"20","key":"90160_CR23","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.3390\/ijms20205232","volume":"20","author":"S Perna","year":"2019","unstructured":"Perna, S. et al. The role of glutamine in the complex interaction between gut microbiota and health: A narrative review. Int. J. Mol. Sci. 20(20), 5232 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"90160_CR24","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/nu15030782","volume":"15","author":"G Song","year":"2023","unstructured":"Song, G. et al. Fructose stimulated colonic arginine and proline metabolism dysbiosis, altered microbiota and aggravated intestinal barrier dysfunction in DSS-induced colitis rats. Nutrients. 15(3), 782 (2023).","journal-title":"Nutrients."},{"issue":"7","key":"90160_CR25","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/ibd\/izac281","volume":"29","author":"R Ferru-Cl\u00e9ment","year":"2023","unstructured":"Ferru-Cl\u00e9ment, R. et al. Serum lipidomic screen identifies key metabolites, pathways, and disease classifiers in Crohn\u2019s disease. Inflamm. Bowel. Dis. 29(7), 1024\u20131037 (2023).","journal-title":"Inflamm. Bowel. Dis."},{"key":"90160_CR26","doi-asserted-by":"publisher","first-page":"175628481988130","DOI":"10.1177\/1756284819881304","volume":"12","author":"E Dudzi\u0144ska","year":"2019","unstructured":"Dudzi\u0144ska, E. et al. Increased expression of kynurenine aminotransferases mRNA in lymphocytes of patients with inflammatory bowel disease. Therap. Adv. Gastroenterol. 12, 1756284819881304 (2019).","journal-title":"Therap. Adv. Gastroenterol."},{"issue":"1","key":"90160_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000496293","volume":"79","author":"JM Gostner","year":"2020","unstructured":"Gostner, J. M. et al. Tryptophan metabolism and related pathways in psychoneuroimmunology: The impact of nutrition and lifestyle. Neuropsychobiology. 79(1), 89\u201399 (2020).","journal-title":"Neuropsychobiology."},{"issue":"1","key":"90160_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/jgh.16043","volume":"38","author":"KG Upadhyay","year":"2023","unstructured":"Upadhyay, K. G., Desai, D. C., Ashavaid, T. F. & Dherai, A. J. Microbiome and metabolome in inflammatory bowel disease. J. Gastroenterol. Hepatol. 38(1), 34\u201343 (2023).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"90160_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1084\/jem.20171965","volume":"215","author":"H Shapiro","year":"2018","unstructured":"Shapiro, H., Kolodziejczyk, A. A., Halstuch, D. & Elinav, E. Bile acids in glucose metabolism in health and disease. J. Exp. Med. 215(2), 383\u2013396 (2018).","journal-title":"J. Exp. Med."},{"key":"90160_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.829525","volume":"13","author":"JP Thomas","year":"2022","unstructured":"Thomas, J. P., Modos, D., Rushbrook, S. M., Powell, N. & Korcsmaros, T. The emerging role of bile acids in the pathogenesis of inflammatory bowel disease. Front. Immunol. 13, 829525 (2022).","journal-title":"Front. Immunol."},{"issue":"9","key":"90160_CR31","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1080\/00365521.2023.2200518","volume":"58","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. Bile acid alterations associated with indolent course of inflammatory bowel disease. Scand. J. Gastroenterol. 58(9), 988\u2013997 (2023).","journal-title":"Scand. J. Gastroenterol."},{"key":"90160_CR32","doi-asserted-by":"publisher","first-page":"1680008","DOI":"10.1155\/2022\/1680008","volume":"2022","author":"R Sun","year":"2022","unstructured":"Sun, R., Jiang, J., Yang, L., Chen, L. & Chen, H. Alterations of serum bile acid profile in patients with Crohn\u2019s disease. Gastroenterol. Res. Pract. 2022, 1680008 (2022).","journal-title":"Gastroenterol. Res. Pract."},{"issue":"1","key":"90160_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/nu11010025","volume":"11","author":"J Connors","year":"2018","unstructured":"Connors, J., Dawe, N. & Van Limbergen, J. The role of succinate in the regulation of intestinal inflammation. Nutrients. 11(1), 25 (2018).","journal-title":"Nutrients."},{"key":"90160_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-immunol-081619-104850","volume":"38","author":"DG Ryan","year":"2020","unstructured":"Ryan, D. G. & O\u2019Neill, L. A. Krebs cycle reborn in macrophage immunometabolism. Annu. Rev. Immunol. 38, 289\u2013313 (2020).","journal-title":"Annu. Rev. Immunol."},{"issue":"7444","key":"90160_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"G Tannahill","year":"2013","unstructured":"Tannahill, G. et al. Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature. 496(7444), 238\u2013242 (2013).","journal-title":"Nature."},{"issue":"7","key":"90160_CR36","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/cr.2015.68","volume":"25","author":"B Kelly","year":"2015","unstructured":"Kelly, B. & O\u2019neill, L. A. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell. Res. 25(7), 771\u2013784 (2015).","journal-title":"Cell. Res."},{"issue":"1","key":"90160_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","volume":"132","author":"JF Colombel","year":"2007","unstructured":"Colombel, J. F. et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn\u2019s disease: The CHARM trial. Gastroenterology 132(1), 52\u201365 (2007).","journal-title":"Gastroenterology"},{"issue":"11","key":"90160_CR38","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/ecco-jcc\/jjy101","volume":"12","author":"F Probert","year":"2018","unstructured":"Probert, F. et al. Plasma nuclear magnetic resonance metabolomics discriminates between high and low endoscopic activity and predicts progression in a prospectived cohort of patients with ulcerative colitis. J. Crohns Colitis. 12(11), 1326\u20131337 (2018).","journal-title":"J. Crohns Colitis."},{"issue":"2","key":"90160_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/ibd\/izad154","volume":"30","author":"L Aldars-Garc\u00eda","year":"2024","unstructured":"Aldars-Garc\u00eda, L. et al. Serum and urine metabolomic profiling of newly diagnosed treatment-na\u00efve inflammatory bowel disease patients. Inflamm. Bowel. Dis. 30(2), 167\u2013182 (2024).","journal-title":"Inflamm. Bowel. Dis."},{"issue":"3","key":"90160_CR40","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/ecco-jcc\/jjac149","volume":"17","author":"N Nystr\u00f6m","year":"2023","unstructured":"Nystr\u00f6m, N. et al. Mucosal and plasma metabolomes in new-onset paediatric inflammatory bowel disease: Correlations with disease characteristics and plasma inflammation protein markers. J. Crohns Colitis. 17(3), 418\u2013432 (2023).","journal-title":"J. Crohns Colitis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90160-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90160-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90160-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T10:49:02Z","timestamp":1739616542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90160-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90160"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90160-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5661"}}